Delivery Order SPE2DR25D2101-SPE2DR26F47TX
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order, valued at $5,912.18, was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The order is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $20,699.87 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside award performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, executed this order as a child contract under its...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.32 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,019.18 to AmerisourceBergen Drug Corp for 20,000 units of Recothrom on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of 20,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,729.60 and an ultimate completion date of December 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $11,306.34, was competitively awarded with an ultimate completion date of December 17, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This firm fixed-price delivery order, valued at $2,567.33, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- This delivery order, valued at $2,463.48, was awarded to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Recothrom pharmaceutical product totaling 20,000 units. The contract is a firm fixed price delivery order with a completion date of December 31, 2025, issued by the Defense Logistics Agency (DLA) through its Medical Supply Chain operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 unit vials of RECOTHROM pharmaceutical product. The $2,670.60 order has a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $33,704.33 to Amerisourcebergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical settings. This competitive, firm fixed-price contract is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating full and open competition among...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47TXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,391.95 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical procurement needs across multiple therapeutic domains through open competition. This delivery order for Recothrom, a hemostatic agent used in surgical applications, reflects the company's ongoing role in supplying specialized medical products to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/26/26 |